Nukkleus (NASDAQ:NUKK - Get Free Report)'s stock had its "sell (d)" rating reiterated by equities researchers at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.
Nukkleus Price Performance
NASDAQ:NUKK opened at $8.00 on Wednesday. Nukkleus has a 1-year low of $1.30 and a 1-year high of $78.32. The business's fifty day moving average price is $5.41 and its 200 day moving average price is $10.31.
Nukkleus (NASDAQ:NUKK - Get Free Report) last posted its quarterly earnings results on Thursday, August 14th. The company reported $0.22 earnings per share for the quarter.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of NUKK. XTX Topco Ltd acquired a new position in Nukkleus in the 1st quarter worth about $125,000. Compagnie Lombard Odier SCmA acquired a new position in Nukkleus in the 1st quarter worth about $74,000. Finally, BNP Paribas Financial Markets acquired a new position in Nukkleus in the 2nd quarter worth about $56,000. 12.47% of the stock is owned by institutional investors and hedge funds.
About Nukkleus
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nukkleus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.
While Nukkleus currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
